As we embark on a new era of genomics, genetic testing
has become increasingly significant in enhancing
individualised health care. Tests to identify susceptibilities
to common diseases like cancer and diabetes will soon
provide a guide to preventive care.
The potential benefits of identifying a patient’s polygenic
risk score and storing their blood/DNA samples is that
it can be used to predict their future susceptibility to
disease. In addition to early diagnosis of rare and chronic
diseases, it can also be used to identify safer and more
effective drug therapy based on their DNA response to
prescribed medication.
Polygene has partnered with DNAlysis to deliver the gold
standard of quality genetic testing and validated results.
